Rule
This market resolves YES if a major trade publication (NutraIngredients-USA, Natural Products Insider, Nutritional Outlook, or INSIDER) or business press outlet (Bloomberg, Reuters, WSJ, Forbes) reports that Urolithin A was the top-selling longevity-positioned single ingredient supplement by US retail dollar sales in 2026, based on their year-end market analysis or industry reporting published by April 21, 2027. NO if no such report emerges or another ingredient is identified as the leader.
Source: https://www.spins.com/
Resolves by Apr 28, 2027.
21 comments
yes at 73 feels too clean.
urolithin a isn't at Target yet and i've looked. if it lands there by end of year, i'm moving.
urolithin a needs a whole paragraph to explain what it does lol
founder's actually shipping here, not just talking about cellular aging at dinner parties. that's the tell
shipping timeline's the only thing that matters here, and if they're still stuck in clinical validation theater past q3 next year
i don't know what urolithin A is but my book club keeps talking about pomegranate extract and whether it actually does anything
urolithin a's got real mitochondrial data behind it, not just influencer theater
urolithin a has the kettle playbook down, single-molecule story, credible but not yet commoditized
urolithin a is real but the category's gonna fracture into stacks before a single ingredient wins